1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc.

TNDM
Tandem Diabetes Care, Inc.US flagNASDAQ Global Market
16.91
USD
-0.69
- -
1.16BMarket Cap

Total Valuation

Tandem Diabetes Care, Inc. carries a market capitalization of 1.16B, placing it among publicly traded companies globally. Its enterprise value stands at 1.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.16B
Enterprise Value1.46B

Share Statistics

Tandem Diabetes Care, Inc. currently has 68.50M shares outstanding.

Shares Outstanding68.50M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.26, and the price-to-book ratio stands at -1.02.

PE RatioN/A
PS Ratio1.26
PB Ratio-1.02
P/TBV Ratio9.81
P/FCF Ratio16.66
P/OCF Ratio66.25

Enterprise Valuation

EV / Sales1.42
EV / EBITDAN/A
EV / EBITN/A
EV / FCF17.38

Financial Position

Tandem Diabetes Care, Inc. maintains a current ratio of 3.58, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 554.92, indicating elevated leverage, while an interest coverage ratio of -7.14 demonstrates limited ability to service its debt obligations.

Current Ratio3.58
Quick Ratio2.87
Debt / Equity554.92
Debt / EBITDA-15.97
Interest Coverage-7.14

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-9.11
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)19.20
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.46

Taxes

Over the trailing twelve months, Tandem Diabetes Care, Inc. has paid -3.51M in income taxes, reflecting an effective tax rate of 112.58.

Income Tax-3.51M
Effective Tax Rate112.58

Stock Price Statistics

Tandem Diabetes Care, Inc.'s stock has gained approximately 4.70588% over the past 52 weeks. The 50-day moving average sits at 15.96, while the 200-day moving average is 18.89.

Beta (5Y)N/A
52-Week Price Change4.70588%
50-Day Moving Average15.96
200-Day Moving Average18.89
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Tandem Diabetes Care, Inc. generated 1.03B in revenue and converted that into -94.55M in net income, yielding earnings per share of -1.39. EBITDA reached -46.00M, while operating income came in at -63.86M.

Revenue1.03B
Gross Profit564.40M
Operating Income-63.86M
Pretax Income-98.06M
Net Income-94.55M
EBITDA-46.00M
EBIT-63.86M
Earnings Per Share (EPS)-1.39

Balance Sheet

Tandem Diabetes Care, Inc. holds 570.26M in cash and equivalents against 734.74M in total debt, resulting in a net debt position of 422.44M. Total book value stands at -1.27B, with working capital of 639.14M providing operational flexibility.

Cash & Cash Equivalents570.26M
Total Debt734.74M
Net Debt422.44M
Equity (Book Value)-1.27B
Book Value Per Share-18.78
Working Capital639.14M

Cash Flow

Tandem Diabetes Care, Inc. produced 19.61M in operating cash flow over the past twelve months. After subtracting -58.37M in capital expenditures, free cash flow totaled -38.76M - equivalent to -0.57 per share.

Operating Cash Flow19.61M
Capital Expenditures-58.37M
Free Cash Flow-38.76M
FCF Per Share-0.57

Margins

Tandem Diabetes Care, Inc. operates with a gross margin of 54.93, reflecting its pricing power and cost economics. The operating margin of -6.22 and net profit margin of -9.20 provide insight into operational efficiency.

Gross Margin54.93
Operating Margin-6.22
Pretax Margin-9.54
Profit Margin-9.20
EBITDA Margin-4.48

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-18.12
FCF Yield6.00

Stock Splits

Tandem Diabetes Care, Inc.'s most recent stock split took place on October 10, 2017 with a 10:1 split ratio.

Last Split Date10/10/2017
Split Ratio10:1

Scores

Tandem Diabetes Care, Inc. posts an Altman Z-Score of 0.59, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.59